Consistency and Completeness of Reported Outcomes in Randomized Trials of Primary Immunosuppression in Kidney Transplantation

Author:

Masson P.12,Duthie F. A.3,Ruster L. P.1,Kelly P. J.1,Merrifield A.1,Craig J. C.12,Webster A. C.124

Affiliation:

1. Sydney School of Public Health; University of Sydney; NSW Australia

2. Cochrane Renal Group; Centre for Kidney Research; Children's Hospital at Westmead; NSW Australia

3. Department of Renal Medicine; Royal Infirmary of Edinburgh; Scotland United Kingdom

4. Centre for Renal and Transplant Research; Westmead Hospital; NSW Australia

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference23 articles.

1. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews;Kirkham;Br Med J,2010

2. Comparison of registered and published primary outcomes in randomized controlled trials;Mathieu;J Am Med Assoc,2009

3. A taxpayer-funded clinical trials registry and results database;Turner;PLoS Med,2004

4. Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients;Webster;Cochrane Database Syst Rev,2005

5. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes;Nissen;N Engl J Med,2007

Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3